Home » Topics » Regulatory » EMA

EMA
RSS

Votubia recommended for approval in Europe

Sep. 26, 2012

EMA committee recommends approval of enzyme-based debriding agent for burn care

Sep. 26, 2012

Avastin recommended for approval of recurrent, platinum-sensitive ovarian cancer in Europe

Sep. 26, 2012

Novartis obtains positive CHMP opinions for Galvus and Eucreas

Sep. 26, 2012

CHMP gives positive opinion on Cialis in new indication

Sep. 26, 2012

CHMP recommends VEGF Trap-Eye in wet AMD

Sep. 26, 2012

CHMP recommends expanded approval of Trajenta tablets

Sep. 25, 2012

CHMP recommends Constella in IBS-C

Sep. 25, 2012

EMA committee recommends approval of new apixaban indication

Sep. 25, 2012

Biovest provides update on planned MAA for NHL vaccine candidate

Sep. 21, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...